This brochure details the AB5000 and how it allows for early identification of off-target effects and mitigating risks in antibody drug development programs. Its innovative approach enables the screening of antibodies against 5469 naturally expressed human membrane proteins in live cells. AB5000 also offers rapid, straightforward, and highly sensitive assessment of binding via ADCC, utilizing a reporter cell line.
Download the Brochure Now